The discovery of a blood test predicts the need of artificial respiratory patients
The discovery of a blood test predicts the need of artificial respiratory patients
5/7/2020
Scientists from the University of Virginia Medical School of America have uncovered a blood test that could make a fundamental difference to the treatment of the Corona virus by predicting a patient's need for a respiratory system early in an infection.
This test may subject patients at risk to close monitoring and intensive care, and help explain how other diseases such as diabetes negatively affect the outcome of patient treatment.
Scientists conducted a study of 57 corona patients requiring a respirator, and the researchers compared blood samples with blood samples from patients who did not need a respirator.
The researchers found that the cytokines proteins that lead to an overactive reaction of the immune system, known as the cytokine storm, could be an indication of severe respiratory distress in SK patients in an advanced stage of infection.
Researcher Dr. Bill Petrie, Head of the Department of Infectious Diseases at the University of Charlottesville said: “The immune response that we have discovered to predict severe shortness of breath in Corona patients is known to cause harm to other lung diseases.”
He added: "Immune cytokine inhibition can lead to the discovery of a new way to prevent respiratory failure in people with the new coronavirus."
The results also showed that there are higher levels of cytokines in patients with high blood sugar, which explains why diabetes is associated with poor coronary patients.
According to Petri, the discovery of cytokines highlights how the immune system interacts with the Corona infection, and may help doctors develop immunotherapy for the virus.
The researchers shared the results of their preliminary research on June 28 on medRxiv.org, according to the UBI website.
